EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) in cancer: a patent review

Massimiliano Gasparrini, Simone Giovannuzzi, Alessio Nocentini, Nadia Raffaelli, Claudiu T Supuran

Expert Opinion on Therapeutic Patents · 2024

DOI: 10.1080/13543776.2024.2367006 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Expert Opinion on Therapeutic Patents, 2024. Verfasst von Massimiliano Gasparrini und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Agriculture, Food and Environmental Sciences, Polytechnic University of Marche, Ancona, Italy. Hauptthemen laut MEDLINE: Nicotinamide Phosphoribosyltransferase, Patents as Topic, Neoplasms, NAD. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 114 Literaturangaben. Gefördert von: This manuscript was funded by University research funding 2022 of Polytechnic University of Marche to MG.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nicotinamide PhosphoribosyltransferasePatents as TopicNeoplasmsNADAntineoplastic AgentsCytokinesEnzyme InhibitorsHumansAnimalsDrug DevelopmentDrug Design

Stichwörter der Autor:innen

CancerNAMPTenzymatic activityinflammationinhibitornovel compounds

Substanzen

Nicotinamide PhosphoribosyltransferaseNADAntineoplastic AgentsCytokinesEnzyme Inhibitorsnicotinamide phosphoribosyltransferase, human

Autor:innen und Institutionen

  • Department of Agriculture, Food and Environmental Sciences, Polytechnic University of Marche, Ancona, Italy.
  • NEUROFARBA Department, Pharmaceutical Chemistry Section, University of Florence, Sesto Fiorentino, Florence, Italy.

Förderung

  • This manuscript was funded by University research funding 2022 of Polytechnic University of Marche to MG

Zitieren

APA

Gasparrini, M., Giovannuzzi, S., Nocentini, A., Raffaelli, N., & Supuran, C. T. (2024). Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) in cancer: a patent review. Expert Opinion on Therapeutic Patents. https://doi.org/10.1080/13543776.2024.2367006

Vancouver

Gasparrini M, Giovannuzzi S, Nocentini A, Raffaelli N, Supuran CT. Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) in cancer: a patent review. Expert Opinion on Therapeutic Patents. 2024. doi:10.1080/13543776.2024.2367006

BibTeX
@article{Gasparrini2024,
  author = {Gasparrini, Massimiliano and Giovannuzzi, Simone and Nocentini, Alessio and Raffaelli, Nadia and Supuran, Claudiu T},
  title = {Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) in cancer: a patent review},
  journal = {Expert Opinion on Therapeutic Patents},
  year = {2024},
  doi = {10.1080/13543776.2024.2367006}
}
Kostenlos starten →